CLINICAL TRIALS PROFILE FOR LEVULAN
✉ Email this page to a colleague
All Clinical Trials for LEVULAN
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00524485 ↗ | Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis | Terminated | National Cancer Institute (NCI) | N/A | 2005-05-01 | RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, abnormal cells are killed. Photodynamic therapy using topical aminolevulinic acid may be effective against actinic keratosis. PURPOSE: This randomized clinical trial is studying how well different photodynamic therapy regimens using topical aminolevulinic acid work in treating patients with actinic keratosis. |
| NCT00524485 ↗ | Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis | Terminated | Roswell Park Cancer Institute | N/A | 2005-05-01 | RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, abnormal cells are killed. Photodynamic therapy using topical aminolevulinic acid may be effective against actinic keratosis. PURPOSE: This randomized clinical trial is studying how well different photodynamic therapy regimens using topical aminolevulinic acid work in treating patients with actinic keratosis. |
| NCT00706433 ↗ | Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne | Completed | DUSA Pharmaceuticals, Inc. | Phase 2 | 2007-03-01 | The purpose of this study is to determine and compare the safety and efficacy of multiple broad area photodynamic therapy treatments with aminolevulinic acid (ALA-PDT) and vehicle (VEH-PDT) in subjects with moderate to severe facial acne vulgaris. |
| NCT00865878 ↗ | ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients | Terminated | DUSA Pharmaceuticals, Inc. | Phase 2 | 2009-05-01 | The purpose of this study is to determine and compare the safety and efficacy of broad area photodynamic therapy with aminolevulinic acid (ALA-PDT) versus vehicle PDT (VEH-PDT) in the treatment of actinic keratoses (AK) and reduction of new non-melanoma skin cancer (NMSC) of the scalp or both forearms in solid organ transplant recipient subjects receiving chronic immunosuppressive therapy. |
| NCT01053000 ↗ | Photodynamic Therapy With Levulan® +/- Topical Retinoid Pre-Treatment In The Treatment Of Actinic Keratoses | Completed | Stewart, Roger H., M.D., P.A. | N/A | 2010-01-01 | To determine and compare the safety and efficacy of broad area photodynamic therapy with aminolevulinic acid (ALA-PDT) following topical retinoid pre-treatment vs ALA-PDT with occlusion only (no pretreatment) in subjects with dorsal hand/forearm actinic keratoses, with an incubation time of 60 minutes, using blue light. |
| NCT01351519 ↗ | A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors | Terminated | MultiCare Health System Research Institute | Phase 2 | 2011-05-01 | In this study subjects will be administered a single oral dose of Aminolevulinic Acid (ALA) prior to surgical resection of their brain tumor. The ALA ultimately causes brain tumor tissue to fluoresce or light up under ultraviolet light. During surgery an ultraviolet light in the microscope chain will be turned on. The tumor tissue will fluoresce bright pink allowing the surgeon to more easily differentiate tumor tissue from normal brain tissue. The aim of the study is to determine whether ALA and fluorescent visualization of tumor tissue improves the surgeon's ability to completely resect or remove the brain tumor. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LEVULAN
Condition Name
Clinical Trial Locations for LEVULAN
Trials by Country
Clinical Trial Progress for LEVULAN
Clinical Trial Phase
Clinical Trial Sponsors for LEVULAN
Sponsor Name
